Back to RLMD
UBS Group AG RLMD Position History
Relmada Therapeutics, Inc. • Healthcare
Quarters held
17
Latest value
$29K
Q3 2026
Peak value
$1.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $704 |
| Q3 2025 | $119K |
| Q3 2025 | $34 |
| Q4 2025 | $2K |
| Q4 2025 | $194K |
| Q4 2025 | $82 |
| Q4 2025 | $4K |
| Q1 2026 | $2K |
| Q1 2026 | $825K |
| Q1 2026 | $54K |
| Q2 2026 | $2K |
| Q2 2026 | $749K |
| Q2 2026 | $27K |
| Q2 2026 | $316K |
| Q3 2026 | $1K |
| Q3 2026 | $1.5M |
| Q3 2026 | $29K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $29K | 7.6K | — | — |
| Q3 2026 | $1.5M | 397.6K | — | — |
| Q3 2026 | $1K | 350 | — | — |
| Q2 2026 | $316K | 45.7K | — | — |
| Q2 2026 | $27K | 3.9K | — | — |
| Q2 2026 | $749K | 108.2K | — | — |
| Q2 2026 | $2K | 350 | — | — |
| Q1 2026 | $54K | 7.8K | — | — |
| Q1 2026 | $825K | 118.5K | — | — |
| Q1 2026 | $2K | 350 | — | — |
| Q4 2025 | $4K | 927 | — | — |
| Q4 2025 | $82 | 17 | — | — |
| Q4 2025 | $194K | 40.2K | — | — |
| Q4 2025 | $2K | 350 | — | — |
| Q3 2025 | $34 | 17 | — | — |
| Q3 2025 | $119K | 59.4K | — | — |
| Q3 2025 | $704 | 350 | — | — |